Cargando…

Key Players in Choline Metabolic Reprograming in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC), defined as lack of estrogen and progesterone receptors in the absence of protein overexpression/gene amplification of human epidermal growth factor receptor 2, is still a clinical challenge despite progress in breast cancer care. (1)H magnetic resonance spectros...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iorio, Egidio, Caramujo, Maria José, Cecchetti, Serena, Spadaro, Francesca, Carpinelli, Giulia, Canese, Rossella, Podo, Franca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043614/ https://www.ncbi.nlm.nih.gov/pubmed/27747192 http://dx.doi.org/10.3389/fonc.2016.00205

Ejemplares similares

Activation of Phosphatidylcholine-Specific Phospholipase C in Breast and Ovarian Cancer: Impact on MRS-Detected Choline Metabolic Profile and Perspectives for Targeted Therapy
por: Podo, Franca, et al.
Publicado: (2016)

Choline Metabolism Alteration: A Focus on Ovarian Cancer
por: Bagnoli, Marina, et al.
Publicado: (2016)

Editorial: Exploring Cancer Metabolic Reprogramming through Molecular Imaging
por: Podo, Franca, et al.
Publicado: (2017)

In vivo Magnetic Resonance Metabolic and Morphofunctional Fingerprints in Experimental Models of Human Ovarian Cancer
por: Canese, Rossella, et al.
Publicado: (2016)

Phosphatidylcholine-specific phospholipase C inhibition down- regulates CXCR4 expression and interferes with proliferation, invasion and glycolysis in glioma cells
por: Mercurio, Laura, et al.
Publicado: (2017)

Phosphatidylcholine-specific phospholipase C inhibition reduces HER2-overexpression, cell proliferation and in vivo tumor growth in a highly tumorigenic ovarian cancer model
por: Paris, Luisa, et al.
Publicado: (2017)

Tumor-Associated Macrophages: Key Players in Triple-Negative Breast Cancer
por: Qiu, Xia, et al.
Publicado: (2022)

Effect of Pantethine on Ovarian Tumor Progression and Choline Metabolism
por: Penet, Marie-France, et al.
Publicado: (2016)

Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells
por: Abalsamo, Laura, et al.
Publicado: (2012)

Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Sun, Xiangyu, et al.
Publicado: (2020)

Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells
por: Paris, Luisa, et al.
Publicado: (2010)

A novel roadmap connecting the (1)H-MRS total choline resonance to all hallmarks of cancer following targeted therapy
por: Iorio, Egidio, et al.
Publicado: (2021)

Inhibition of Phosphatidylcholine-Specific Phospholipase C Interferes with Proliferation and Survival of Tumor Initiating Cells in Squamous Cell Carcinoma
por: Cecchetti, Serena, et al.
Publicado: (2015)

Global metabolic profile identifies choline kinase alpha as a key regulator of glutathione-dependent antioxidant cell defense in ovarian carcinoma
por: Granata, Anna, et al.
Publicado: (2015)

Nuclear Phosphoinositide-Specific Phospholipase C β1 Controls Cytoplasmic CCL2 mRNA Levels in HIV-1 gp120-Stimulated Primary Human Macrophages
por: Spadaro, Francesca, et al.
Publicado: (2013)

Chemo-immunotherapy induces tumor regression in a mouse model of spontaneous mammary carcinogenesis
por: Aricò, Eleonora, et al.
Publicado: (2016)

Metabolomic Reprogramming Detected by (1)H-NMR Spectroscopy in Human Thyroid Cancer Tissues
por: Metere, Alessio, et al.
Publicado: (2020)

Identification of Key Genes Affecting the Tumor Microenvironment and Prognosis of Triple-Negative Breast Cancer
por: Yi, Jiarong, et al.
Publicado: (2021)

Tumor Microenvironment: Key Players in Triple Negative Breast Cancer Immunomodulation
por: Zheng, Hongmei, et al.
Publicado: (2021)

Inflammation and Metabolism in Cancer Cell—Mitochondria Key Player
por: Neagu, Monica, et al.
Publicado: (2019)

In vivo targeting of cutaneous melanoma using an MSH-engineered human protein cage bearing fluorophore and MRI tracers
por: Vannucci, Luca, et al.
Publicado: (2014)

Choline metabolism and its implications in cancer
por: Yao, Nan, et al.
Publicado: (2023)

Cuproptosis in ccRCC: key player in therapeutic and prognostic targets
por: Lv, Yang, et al.
Publicado: (2023)

Metabolic reprogramming in triple-negative breast cancer
por: Wang, Zhanyu, et al.
Publicado: (2020)

Identification of Potential Key Genes Associated With the Pathogenesis, Metastasis, and Prognosis of Triple-Negative Breast Cancer on the Basis of Integrated Bioinformatics Analysis
por: Zhao, Bin, et al.
Publicado: (2020)

Prospects of Immunotherapy for Triple-Negative Breast Cancer
por: Qiu, Dan, et al.
Publicado: (2022)

Nanomaterial Technology and Triple Negative Breast Cancer
por: Hou, Kai, et al.
Publicado: (2022)

The Tumor Microenvironment Modulates Choline and Lipid Metabolism
por: Mori, Noriko, et al.
Publicado: (2016)

Choline PET/CT in recurrent prostate cancer
por: Detti, Beatrice, et al.
Publicado: (2023)

Targeted Therapeutic Strategies for Triple-Negative Breast Cancer
por: Li, Ying, et al.
Publicado: (2021)

Rewiring of the Endocrine Network in Triple-Negative Breast Cancer
por: Li, Kaixuan, et al.
Publicado: (2022)

Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer
por: Luo, Chenyi, et al.
Publicado: (2022)

Current Management Strategies in Breast Cancer by Targeting Key Altered Molecular Players
por: Ali, Shazia, et al.
Publicado: (2016)

Editorial: Transcriptional Regulation as a Key Player in Cancer Cells Drug Resistance
por: Martinez-Balibrea, Eva, et al.
Publicado: (2021)

YY1 Is a Key Player in Melanoma Immunotherapy/Targeted Treatment Resistance
por: Kwiatkowska, Dominika, et al.
Publicado: (2022)

Key regulator PNPLA8 drives phospholipid reprogramming induced proliferation and migration in triple-negative breast cancer
por: Tan, Zheqiong, et al.
Publicado: (2023)

Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer
por: Granata, A, et al.
Publicado: (2014)

Changes in total choline concentration in the breast of healthy fertile young women in relation to menstrual cycle or use of oral contraceptives: a 3-T (1)H-MRS study
por: Di Leo, Giovanni, et al.
Publicado: (2018)

Sialic Acid Metabolism: A Key Player in Breast Cancer Metastasis Revealed by Metabolomics
por: Teoh, Shao Thing, et al.
Publicado: (2018)

Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy
por: Chasov, Vitaly, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p26jkv3ef2hsdpvlrjg56820bf